Nonprofit · EIN 81-4885713
ANSWER2CANCER
Tax-exempt · BEAVERTON, OR 97007
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990-EZ | $1 | $10,388 | -$10,387 | $26,505 | $10,522 | $15,983 |
| December 31, 2024 | 990-EZ | $10,050 | $2,432 | $7,618 | $36,892 | $10,522 | $26,370 |
| December 31, 2023 | 990-EZ | $2,126 | $3,938 | -$1,812 | $29,274 | $10,522 | $18,752 |
| December 31, 2021 | 990-EZ | $9,144 | $3,059 | $6,085 | $27,347 | $14,345 | $13,002 |
Financial details: 990-EZ for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $0
- Program service revenue
- $0
- Investment income
- $1
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $0
- Salaries, compensation and benefits (total)
- $0
- Professional fees and payments to contractors
- $1,800
- Other expenses
- $8,588
Balance sheet and other
- Total assets, start of year
- $36,892
- Total assets, end of year
- $26,505
- Total liabilities, end of year
- $10,522
- Net assets, end of year
- $15,983
- Cash, savings and investments
- $26,505
- Gross receipts
- $1
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990-EZ for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Dianne J Danowski-Smith | President | 10 | $0 |
| Andrew D Smith | CFO | 2 | $0 |
| Elaine Denning | Secretary | 3 | $0 |
| Rosemary McDermott | Nursing Consultant | 3 | $0 |
990-EZ for the year ended December 31, 2024: 4 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Dianne J Danowski-Smith | President | 10 | $0 |
| Andrew D Smith | CFO | 2 | $0 |
| Elaine Denning | Secretary | 5 | $0 |
| Rosemary McDermott | Nursing Consultant | 5 | $0 |
990-EZ for the year ended December 31, 2023: 4 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Dianne J Danowski-Smith | President | 15 | $0 |
| Andrew D Smith | CFO | 3 | $0 |
| Elaine Denning | Secretary | 1 | $0 |
| Rosemary McDermott | Nursing Consultant | 10 | $0 |
990-EZ for the year ended December 31, 2021: 4 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Dianne J Danowski-Smith | President | 15 | $0 |
| Andrew D Smith | CFO | 7 | $0 |
| Elaine Denning | Secretary | 1 | $0 |
| Rosemary McDermott | Nursing Consultant | 15 | $0 |
Address and contacts
- Address (IRS master file)
- 7299 SW LINETTE WAY, BEAVERTON, OR 97007-5099
- In care of
- % DIANNE DANOWSKI SMITH
- Signed the 990-EZ
- Andrew Smith, CFO
- Phone
- (503) 201-7019
- Website
- www.answer2cancer.org
Mission
Answer2Cancer, Inc. is by and for patients who, while going through cancer treatments, realized they didn't know what they didn't know. Those undergoing treatment (and their caregivers) know there is so much to know. Answer2Cancer, Inc. has been created to help patients and their caregivers/helpers overcome the challenges of treatments and learn helpful, healthful survivor strategies.
Program accomplishments
- In 2018, we held Answer2Cancer, Inc. full day event to bring resources, support and education at no charge to Portland, Oregon area cancer patients, their families and caregivers. Nearly 300 people attended the April 7, 2018 event. We also made presentations to community and health groups including Portland Oncology Pharmeceutical Society's leadership team. Additionally, we traveled to and began planning for 2019 and 2020 events in Bellingham, Spokane and the Tri-Cities, Washington. The 2020 event due to COVID-19, was held through an on-line format to reach those who were at higher risk due to suppressed immune systems. The event was held on October 3, 2020 and was title "Answer2Cancer Digital 2020" The event was attended by approximately 275 on-line attendees. In 2021, the focus of the year was education and outreach planning for events in 2022 and 2023.
- Activities and planning 2022-responded and wrote two small Advocacy grants to Pfizer and also applied for Advocate grant from PhRMA. In, October of 2022 traveled to Missoula and Billings Montana regarding the possibility of bringing the A2C program to MT in 2023. Received a favorable reception at both locations from representatives of Johnson & Johnson and the American Cancer Society's Cancer Action Network local director. Following up with Community Cancer Centers In MT and other organizations to begin the process for a summer 2023 event. In October of 2022, also traveled to Boise, ID meeting with a clinical trial specialist who is affiliated with a large health care system there at St. Luke's.
- In 2023, we continued planning for 2024 patient education and support events in Eugene, Billings Montana and Boise Idaho. We worked closely with therapeutical companies to engage in patient education efforts with local health providers, policymakers and patient advocate organizations, to improve access to medicines for the underserved.
- A2C was invited to submit an Advocacy grant to Pfizer, which was funded at $10,000. Funds are being used on a digital media to support/increase awareness of a national patient survey to determine drug cost variables for patients and families. For 2025, working on a pitch for an A2C event in Eugene, in cooperation with the Willamette Valley Cancer institute in Eugene and throughout Lane County
- 2025-Challenging year of reaching out to make deeper partnerships, attended Advocacy Day in Salem. Seeking viable sponsors for 2026 events. Pharmaceutical companies are changing their models and it is more difficult to obtain partnerships for events and programs. Cuts to Federal funding and stronger competition for dollars is creating a challenging environment. The Focus for this year was to develop relationships with partners for smaller events with smaller costs and larger impact. These take time to develop and move through the process. In 2025 A2C was invited to participate in the Advocacy activities with Vertex at the Oregon Capitol in March of 2025. Goal for 2026 is focused on a potential partnership and A2C event in Eugene, in cooperation with the Salem Cancer Community, Oregon Oncology Specialists and Willamette Valley Cancer Institute in Eugene/Lane County.
What it must file and when
IRS records say it files Form 990-N (e-Postcard). Gross receipts normally $50,000 or less. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990-EZ on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990-EZ on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990-EZ on file |
IRS record
- EIN
- 81-4885713
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2017
- Accounting year ends
- December
- Files
- Form 990-N (e-Postcard)
- Category (NTEE)
- Health care (E70)
- Assets (IRS master file)
- $26,505
- Income (IRS master file)
- $1
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990-EZ | December 2025 | $1 | $10,388 | $26,505 | IRS |
| 990-EZ | December 2024 | $10,050 | $2,432 | $36,892 | IRS |
| 990-EZ | December 2023 | $2,126 | $3,938 | $29,274 | XML |
| 990-EZ | December 2022 | – | – | – | IRS |
| 990-EZ | December 2021 | $9,144 | $3,059 | $27,347 | XML |
| 990-EZ | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 81-4885713).
Questions about ANSWER2CANCER
- What is the EIN of ANSWER2CANCER?
- The employer identification number (EIN) of ANSWER2CANCER is 81-4885713.
- Is ANSWER2CANCER tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2017.
- Are donations to ANSWER2CANCER tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does ANSWER2CANCER file?
- Form 990-N (e-Postcard). Gross receipts normally $50,000 or less.
- When is the next return of ANSWER2CANCER due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did ANSWER2CANCER last file with the IRS?
- The latest return in the IRS public files is the 990-EZ for the year ended December 2025.
- Who are the officers and directors of ANSWER2CANCER?
- The 990-EZ for the year ended December 31, 2025 lists 4 people; 0 received compensation from the organization.
- How much revenue does ANSWER2CANCER have?
- On its 990-EZ for the year ended December 31, 2025 it reported revenue of $1, expenses of $10,388 and total assets of $26,505 at year end.
Other nonprofits in BEAVERTON
- SISTERS OF ST MARY OF OREGON MARYVILLE CORPORATION EIN 93-0752805 · last filed 990 for 2025
- ALS UNITED INC EIN 88-3176104 · last filed 990 for 2026
- TOUCHMARK FOUNDATION EIN 83-0330168 · last filed 990 for 2024
- KOMAK EIN 20-8028264 · last filed 990-EZ for 2025
- DESTINY DOCTORS EIN 33-4437983 · last filed 990-EZ for 2025
- NORTHWEST POINT OF CARE EIN 93-2824821 · last filed 990-N for 2025
- 3 RS EQUINE THERAPY CENTER EIN 83-2838738 · last filed 990-N for 2025
- LA LECHE LEAGUE OF THE UNITED STATES OF AMERICA EIN 93-1259939 · last filed 990-N for 2025